Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer
Preprint in Research Square (March 2024)
The most recent citing publications are shown below. View all 49 publications that cite this research output on Dimensions.
Preprint in Research Square (March 2024)
Article in Diagnostics (October 2023)
Article in Frontiers in Pharmacology (August 2023)